Role of NR2F2-mediated reprogramming of endothelial cells in glioblastoma progression.
Overview
- Department of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
- Clinical Biobank, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
- Department of Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
Datasets cited
- figshare:22434341, at figshare; found in the text, “Spatial transcriptomics data analysis”
Code and data availability statement
The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
- it says that the code is available on request
Read it in the paper: doi.org/10.1016/j.isci.2026.115875.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 3 keywords, 1 funder, 55 references, 4 RRIDs.
Cite
This paper
He, J., Wang, X., Zhang, S., Guo, D., & Sun, J. (2026). Role of NR2F2-mediated reprogramming of endothelial cells in glioblastoma progression. iScience, 29(6), 115875. https://
BibTeX
@article{he2026role,
author = {He, Jing and Wang, Xun and Zhang, Sumei and Guo, Dan and Sun, Jian},
title = {{Role of NR2F2-mediated reprogramming of endothelial cells in glioblastoma progression}},
journal = {iScience},
year = {2026},
month = apr,
volume = {29},
number = {6},
pages = {115875},
publisher = {Elsevier},
issn = {2589-0042},
doi = {10.1016/
url = {https://
pmid = {42181255},
pmcid = {PMC13195781}
}
RIS
TY - JOUR
AU - He, Jing
AU - Wang, Xun
AU - Zhang, Sumei
AU - Guo, Dan
AU - Sun, Jian
TI - Role of NR2F2-mediated reprogramming of endothelial cells in glioblastoma progression
T2 - iScience
J2 - iScience
PY - 2026
DA - 2026/
VL - 29
IS - 6
SP - 115875
SN - 2589-0042
PB - Elsevier
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "Role of NR2F2-mediated reprogramming of endothelial cells in glioblastoma progression",
"container-title": "iScience",
"author": [
{
"family": "He",
"given": "Jing"
},
{
"family": "Wang",
"given": "Xun"
},
{
"family": "Zhang",
"given": "Sumei"
},
{
"family": "Guo",
"given": "Dan"
},
{
"family": "Sun",
"given": "Jian"
}
],
"container-title-short":
"volume": "29",
"issue": "6",
"page": "115875",
"DOI": "10.1016/
"PMID": "42181255",
"PMCID": "PMC13195781",
"ISSN": "2589-0042",
"publisher": "Elsevier",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
22
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1016/j.xcrm.2026.102766 [code]
- A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma.Journal: Cell reports. MedicineIn common: genetics / omics, other condition, cellular / molecular, 12 references
- [2] doi:10.1038/s41586-026-10612-6 [code]
- Acquired genetic and cell-state changes in IDH-mutant glioma progression.Journal: NatureIn common: other condition, cellular / molecular, 9 references
- [3] doi:10.1093/neuonc/noaf257
- Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/
6 and mTOR inhibition in a Phase 0/ 1 trial of recurrent high-grade glioma. Journal: Neuro-oncologyIn common: genetics / omics, other condition, 8 references - [4] doi:10.32604/or.2026.079221
- Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.Journal: Oncology researchIn common: genetics / omics, other condition, cellular / molecular, 6 references
- [5] doi:10.1038/s41586-026-10641-1 [code]
- Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.Journal: NatureIn common: other condition, cellular / molecular, 5 references
- [6] doi:10.1038/s41467-026-76587-0 [code]
- Uncovering the signaling networks of disseminated glioblastoma cells in vivo with INSIGHT.Journal: Nature communicationsIn common: genetics / omics, other condition, cellular / molecular, 5 references
- [7] doi:10.3390/cancers18132092
- TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activat
ed Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study. Journal: CancersIn common: genetics / omics, other condition, 5 references - [8] doi:10.1111/jcmm.71154
- Mitophagy-Oxidative Stress Molecular Subtypes Define an Immunosuppressive Ecosystem and Vulnerabilities in Glioblastoma.Journal: Journal of cellular and molecular medicineIn common: genetics / omics, other condition, 5 references
- [9] doi:10.1016/j.xcrm.2026.102850 [code]
- Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma.Journal: Cell reports. MedicineIn common: other condition, 5 references
- [10] doi:10.1038/s12276-026-01801-4 [code]
- Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.Journal: Experimental & molecular medicineIn common: genetics / omics, other condition, cellular / molecular, 4 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.